| Old Articles: <Older 5181-5190 Newer> |
|---|
 |
Pharmaceutical Executive
October 1, 2008
Andrew Levitt |
What's The Buzz What's the buzz all about? Word of mouth is more effective than we think.   |
Pharmaceutical Executive
October 1, 2008 |
Getting "Engaged" Web analytics is helping a new generation of pharma web sites get engaged. |
Pharmaceutical Executive
October 1, 2008
Jill Wechsler |
Part D Under Attack Congressional leaders ready campaign to curb Medicare drug plans. |
Pharmaceutical Executive
October 1, 2008
Walter Armstrong |
The Drug Vote '08 A head-to-head comparison of the Drug Vote '08 |
Pharmaceutical Executive
October 1, 2008
Sarah Houlton |
Open For Debate Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems. |
Pharmaceutical Executive
October 1, 2008
Michael Bonney |
Specialty Sales Gets No Resistance The author, a Cubist Pharmaceuticals CEO. has given his company a successful start and is now predicting the future of drug resistance. |
Pharmaceutical Executive
October 1, 2008
Patrick Clinton |
Future Shock A vision of pharma's next business model is starting to emerge. But how do we get from here to there? |
The Motley Fool
October 16, 2008
Brian Orelli |
Foolish Forecast: Robots on the Cheap Intuitive Surgical releases earnings in a few hours. Here are some premonitions to tide you over as you anxiously wait the news. |
The Motley Fool
October 15, 2008
Brian Orelli |
Abbott's Stents Aren't (That) Important Abbott's shareholders shouldn't be too focused on drug-eluting stents. |
IEEE Spectrum
October 2008
Samuel K. Moore |
U.S. Regulators Approve Magnetic Stimulation Device for Depression Neuronetics' repetitive transcranial magnetic stimulation wins long battle for FDA approval. Questions remain about whether insurers will pay for it |
| <Older 5181-5190 Newer> Return to current articles. |
